Synapse - Works

Results (4073)

Efficacy and safety of crizotinib in patients with advanced ROS1-rearranged non-small cell lung cancer (NSCLC)

Meeting Abstract

Ou, S. H. I.; Bang, Y. J.; Camidge, D. R.; Riely, G. J.; Salgia, R.; Shapiro, G.; Solomon, B. J.; Engelman, J. A.; Kwak, E. L.; Clark, J. W.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Randomized phase II study of gemcitabine (G), cisplatin (C) with or without veliparib (V) (arms A, B) and a phase II single-arm study of single-agent veliparib (arm C) in patients with BRCA or PALB2-mutated pancreas adenocarcinoma (PC)

Meeting Abstract

O'Reilly, E. M.; Lowery, M. A.; Yu, K. H.; Capanu, M.; Stadler, Z. K.; Epstein, A. S.; Golan, T.; Segal, A.; Segal, M.; Salo-Mullen, E. E.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Ipilimumab (Ipi) retreatment at 10 mg/kg in patients with metastatic melanoma previously treated in phase II trials

Meeting Abstract

Neyns, B.; Weber, J. S.; Lebbé, C.; Maio, M.; Harmankaya, K.; Hamid, O.; O'Day, S.; Chin, K. M.; McDowell, D. O.; Cykowski, L.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Phase II, two-stage, two-arm, PIK3CA mutation stratified trial of MK-2206 in recurrent endometrial cancer (EC)

Meeting Abstract

Myers, A. P.; Broaddus, R.; Makker, V.; Konstantinopoulos, P. A.; Drapkin, R.; Horowitz, N. S.; Liu, J.; Van Hummelen, P.; Meric-Bernstam, F.; Birrer, M. J.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Record-3: Phase II randomized trial comparing sequential first-line everolimus (EVE) and second-line sunitinib (SUN) versus first-line SUN and second-line EVE in patients with metastatic renal cell carcinoma (mRCC)

Meeting Abstract

Motzer, R. J.; Barrios, C. H.; Kim, T. M.; Falcon, S.; Cosgriff, T.; Harker, W. G.; Pittman, K. B.; Sabbatini, R.; Rha, S. Y.; Flaig, T. W.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Effective incorporation of biospecimen collection for translational studies into a phase III trial: The NeoALTTO experience (BIG 01-06)

Meeting Abstract

Nuciforo, P.; Jimenez, J.; Aura, C.; Fumagalli, D.; Maetens, M.; Prudkin, L.; Rothe, F.; Vazquez, J.; Loi, S.; Eidtmann, H.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

A phase II study of the selective phosphatidylinositol 3-kinase delta (PI3Kδ) inhibitor idelalisib (GS-1101) in combination with rituximab (R) in treatment-naive patients (pts) ≥ 65 years with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL)

Meeting Abstract

O'Brien, S. M.; Lamanna, N.; Kipps, T. J.; Flinn, I.; Zelenetz, A. D.; Burger, J. A.; Holes, L.; Johnson, D. M.; Gu, J.; Dansey, R. D.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Safety of radium-223 dichloride (Ra-223) with docetaxel (D) in patients with bone metastases from castration-resistant prostate cancer (CRPC): A phase I Prostate Cancer Clinical Trials Consortium Study

Meeting Abstract

Morris, M. J.; Hammers, H. J.; Sweeney, C.; Antonarakis, E. S.; Cho, S. Y.; Pandit-Taskar, N.; Jacene, H.; Bloma, M.; Aksnes, A. K.; O'Bryan-Tear, C. G.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

A phase III comparative study of nivolumab (anti-PD-1; BMS-936558; ONO-4538) versus everolimus in patients (pts) with advanced or metastatic renal cell carcinoma (mRCC) previously treated with antiangiogenic therapy

Meeting Abstract

Motzer, R. J.; Bono, P.; Hudes, G. R.; Tomita, Y.; Ravaud, A.; Waxman, I.; Gore, M. E.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Longer-term cardiac safety and outcomes of dose dense (dd) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) and trastuzumab (H) with and without lapatinib (L) in patients (pts) with early breast cancer (BC)

Meeting Abstract

Morris, P. G.; Iyengar, N. M.; Patil, S.; Chen, C.; Abbruzzi, A.; Lehman, R. J.; Steingart, R.; Oeffinger, K. C.; Lin, N.; Moy, B.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save